LPCN
Price
$3.02
Change
-$0.09 (-2.89%)
Updated
Oct 17 closing price
Capitalization
16.37M
ZNTL
Price
$1.49
Change
-$0.07 (-4.49%)
Updated
Oct 17 closing price
Capitalization
107.48M
15 days until earnings call
Interact to see
Advertisement

LPCN vs ZNTL

Header iconLPCN vs ZNTL Comparison
Open Charts LPCN vs ZNTLBanner chart's image
Lipocine
Price$3.02
Change-$0.09 (-2.89%)
Volume$12.72K
Capitalization16.37M
Zentalis Pharmaceuticals
Price$1.49
Change-$0.07 (-4.49%)
Volume$800.02K
Capitalization107.48M
LPCN vs ZNTL Comparison Chart in %
LPCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LPCN vs. ZNTL commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LPCN is a Hold and ZNTL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (LPCN: $3.02 vs. ZNTL: $1.49)
Brand notoriety: LPCN and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LPCN: 41% vs. ZNTL: 103%
Market capitalization -- LPCN: $16.37M vs. ZNTL: $107.48M
LPCN [@Biotechnology] is valued at $16.37M. ZNTL’s [@Biotechnology] market capitalization is $107.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LPCN’s FA Score shows that 0 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • LPCN’s FA Score: 0 green, 5 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, both LPCN and ZNTL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LPCN’s TA Score shows that 5 TA indicator(s) are bullish while ZNTL’s TA Score has 4 bullish TA indicator(s).

  • LPCN’s TA Score: 5 bullish, 5 bearish.
  • ZNTL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, LPCN is a better buy in the short-term than ZNTL.

Price Growth

LPCN (@Biotechnology) experienced а -2.58% price change this week, while ZNTL (@Biotechnology) price change was -11.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

ZNTL is expected to report earnings on Nov 03, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZNTL($107M) has a higher market cap than LPCN($16.4M). LPCN YTD gains are higher at: -38.115 vs. ZNTL (-50.825). LPCN has higher annual earnings (EBITDA): -5.52M vs. ZNTL (-170.37M). ZNTL has more cash in the bank: 303M vs. LPCN (17.9M). LPCN has less debt than ZNTL: LPCN (1.48M) vs ZNTL (37.7M). ZNTL has higher revenues than LPCN: ZNTL (26.9M) vs LPCN (4.21M).
LPCNZNTLLPCN / ZNTL
Capitalization16.4M107M15%
EBITDA-5.52M-170.37M3%
Gain YTD-38.115-50.82575%
P/E RatioN/AN/A-
Revenue4.21M26.9M16%
Total Cash17.9M303M6%
Total Debt1.48M37.7M4%
FUNDAMENTALS RATINGS
LPCN: Fundamental Ratings
LPCN
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LPCNZNTL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
LPCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMA53.470.64
+1.21%
Banco Macro SA
GENK3.040.03
+1.00%
GEN Restaurant Group
ARIS23.69N/A
N/A
Aris Water Solutions
FTLF17.70-0.99
-5.30%
FitLife Brands Inc
KGC25.10-2.48
-8.99%
Kinross Gold Corp

LPCN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LPCN has been loosely correlated with SPRY. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if LPCN jumps, then SPRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPCN
1D Price
Change %
LPCN100%
-2.89%
SPRY - LPCN
63%
Loosely correlated
-0.59%
HYFT - LPCN
43%
Loosely correlated
-3.66%
ZNTL - LPCN
36%
Loosely correlated
-4.49%
TARA - LPCN
30%
Poorly correlated
-5.02%
JANX - LPCN
30%
Poorly correlated
-1.62%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with NGNE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
-4.49%
NGNE - ZNTL
49%
Loosely correlated
-14.59%
IDYA - ZNTL
45%
Loosely correlated
+5.67%
SYRE - ZNTL
44%
Loosely correlated
+1.03%
DNLI - ZNTL
44%
Loosely correlated
-0.36%
ORMP - ZNTL
43%
Loosely correlated
-1.76%
More